Search results for "symptoms"

showing 10 items of 713 documents

Alliesthesia in visual and auditory sensations from environmental signals.

2007

'Alliesthesia' describes the fact that sensory stimuli can arouse pleasant or unpleasant sensations according to the internal state of a person. In the present work, the hedonicity aroused by stimuli from the environment in visual and auditory sensations was evaluated in 5 situations: 1) daytime without sensory stimulations (no video-tape); 2) daytime with poor sensory stimulations (uninteresting video-tape film); 3) daytime with rich sensory stimulations (interesting chosen movie on video-tape); 4) night-time without sensory stimulations (no video-tape); 5) night-time with poor sensory stimulations (uninteresting video-tape). During the day, hedonic ratings decreased with time in the no- a…

AdultMalemedicine.medical_specialtyAdolescentmedia_common.quotation_subjectSensationExperimental and Cognitive PsychologySensory systemAlliesthesiaAudiologyEnvironmentDevelopmental psychologyAssociationBehavioral NeuroscienceReference ValuesPerceptionSensationAdaptation PsychologicalmedicineHumansAffective SymptomsWakefulnessComputingMilieux_MISCELLANEOUSmedia_commonAnalysis of Variance[SCCO.NEUR]Cognitive science/Neuroscience[SCCO.NEUR] Cognitive science/NeuroscienceAffectAcoustic Stimulation[ SCCO.NEUR ] Cognitive science/NeuroscienceFemalePerceptionPsychologyArousalPhotic Stimulation
researchProduct

Differential effects of high-dose amisulpride versus flupentixol on latent dimensions of depressive and negative symptomatology in acute schizophreni…

2002

While many acutely ill schizophrenic patients suffer from depressive symptoms, most studies on the efficacy of antipsychotic drugs focus on positive and negative symptoms. Dimensional models of schizophrenic symptoms, based on confirmatory factor analysis (CFA) using structural equation modelling, offer a methodological alternative to compare antipsychotics on empirically justified latent factors. The present report is a refined analysis of a published double-blind study on the D 2 /D 3 -selective antagonist amisulpride (ASP) versus the mixed D 1-5 /5-HT 2 antagonist flupentixol (FPX). CFA was applied to Brief Psychiatric Rating Scale, Scale for the Assessment of Negative Symptoms, Bech-Raf…

AdultMalemedicine.medical_specialtyAdolescentmedicine.medical_treatmentDouble-Blind MethodBrief Psychiatric Rating ScalemedicineHumansPharmacology (medical)AmisulprideAntipsychoticPsychiatryScale for the Assessment of Negative SymptomsAgedMiddle Agedmedicine.diseaseConfirmatory factor analysisFlupentixolFlupenthixolPsychiatry and Mental healthAffectPsychotropic drugSchizophreniaSchizophreniaFemaleSchizophrenic PsychologyAmisulprideSulpiridePsychologyFactor Analysis Statisticalmedicine.drugAntipsychotic AgentsInternational clinical psychopharmacology
researchProduct

Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis

2013

© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

AdultMalemedicine.medical_specialtyBipolar DisorderBipolar disorderTrail Making TestReviewNeuropsychological TestsVerbal learning03 medical and health sciencesMental Processes0302 clinical medicineRisk FactorsmedicineMemory spanHumansMental CompetencyAffective SymptomsBipolar disorderAge of OnsetPsychiatryPsychiatric Status Rating ScalesPsychotropic DrugsNeuropsychologyConfounding Factors EpidemiologicMiddle Agedmedicine.disease030227 psychiatryAffectPsychiatry and Mental healthMoodCognitive impairmentSchizophreniaNeuropsychological testsFemaleVerbal memoryCognition DisordersPsychology030217 neurology & neurosurgeryClinical psychology
researchProduct

Antecedents of manic versus other first psychotic episodes in 263 bipolar I disorder patients.

2013

Objective As initial episode type can predict later morbidity in bipolar disorder, we tested the hypothesis that clinical antecedents might predict initial episode types. Method We studied 263 first-episode, adult, DSM-IV-TR type I bipolar disorder (BD-I) subjects within the McLean-Harvard-International First-Episode Project. Based on blinded assessments of antecedents from SCID examinations and clinical records, we compared first lifetime manic vs. other (mixed, depressive, or non-affective) major psychotic episodes. Results We identified 32 antecedents arising at early, intermediate or later times, starting 12.3 ± 10.7 years prior to first lifetime major psychotic episodes. Based on multi…

AdultMalemedicine.medical_specialtyBipolar I disorderBipolar DisorderTime FactorsProdromal SymptomsImpulsivityDysphoriaArticlemental disordersmedicineHumansBipolar disorderPsychiatryDepression (differential diagnoses)Anhedoniamedicine.diseasePrognosisSubstance abusePsychiatry and Mental healthFemalemedicine.symptomPsychologyPsychopathologyClinical psychologyActa psychiatrica Scandinavica
researchProduct

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC st…

2006

Abstract Objective Estimate the prevalence of urinary incontinence (UI), overactive bladder (OAB), and other lower urinary tract symptoms (LUTS) among men and women in five countries using the 2002 International Continence Society (ICS) definitions. Methods This population-based, cross-sectional survey was conducted between April and December 2005 in Canada, Germany, Italy, Sweden, and the United Kingdom using computer-assisted telephone interviews. A random sample of men and women aged ≥ 18 yr residing in the five countries and who were representative of the general populations in these countries was selected. Using 2002 ICS definitions, the prevalence estimates of storage, voiding, and po…

AdultMalemedicine.medical_specialtyCanadaAdolescentCross-sectional studyUrologyPopulationUrinary incontinenceSeverity of Illness IndexAge DistributionLower urinary tract symptomsGermanymedicinePrevalenceNocturiaHumansSex DistributioneducationAgedRetrospective StudiesGynecologySwedeneducation.field_of_studybusiness.industryUrinary Bladder OveractiveMiddle Agedmedicine.diseaseThe Overactive Bladder QuestionnaireUnited KingdomUrodynamicsCross-Sectional StudiesUrinary IncontinenceOveractive bladderItalyPopulation SurveillanceCohortFemalemedicine.symptombusinessDemographyEuropean urology
researchProduct

Complex regional pain syndrome: evidence for warm and cold subtypes in a large prospective clinical sample.

2016

Limited research suggests that there may be Warm complex regional pain syndrome (CRPS) and Cold CRPS subtypes, with inflammatory mechanisms contributing most strongly to the former. This study for the first time used an unbiased statistical pattern recognition technique to evaluate whether distinct Warm vs Cold CRPS subtypes can be discerned in the clinical population. An international, multisite study was conducted using standardized procedures to evaluate signs and symptoms in 152 patients with clinical CRPS at baseline, with 3-month follow-up evaluations in 112 of these patients. Two-step cluster analysis using automated cluster selection identified a 2-cluster solution as optimal. Resul…

AdultMalemedicine.medical_specialtyDatabases FactualPopulationStatistical patternSigns and symptoms610 Medicine & health03 medical and health sciences0302 clinical medicine030202 anesthesiologyInternal medicinemedicineHumansIn patientProspective StudieseducationProspective cohort studyPain MeasurementInflammationeducation.field_of_studyPain durationbusiness.industry10051 Rheumatology Clinic and Institute of Physical MedicineMiddle Agedmedicine.diseaseAnesthesiology and Pain MedicineComplex regional pain syndrome2728 Neurology (clinical)PhenotypeNeurologyAnesthesia2808 Neurology10046 Balgrist University Hospital Swiss Spinal Cord Injury CenterFemaleNeurology (clinical)2703 Anesthesiology and Pain Medicinebusiness030217 neurology & neurosurgeryComplex Regional Pain SyndromesPain
researchProduct

What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?

2014

AbstractBackground:Aim was to examine depressive symptoms in acutely ill schizophrenia patients on a single symptom basis and to evaluate their relationship with positive, negative and general psychopathological symptoms.Methods:Two hundred and seventy-eight patients suffering from a schizophrenia spectrum disorder were analysed within a naturalistic study by the German Research Network on Schizophrenia. Using the Calgary Depression Scale for Schizophrenia (CDSS) depressive symptoms were examined and the Positive and Negative Syndrome Scale (PANSS) was applied to assess positive, negative and general symptoms. Correlation and factor analyses were calculated to detect the underlying structur…

AdultMalemedicine.medical_specialtyDepression scaleMedizinSeverity of Illness Index03 medical and health sciences0302 clinical medicineGermanyPrevalencemedicineHumans030212 general & internal medicinePsychiatryDepression (differential diagnoses)Depressive symptomsPsychiatric Status Rating ScalesPositive and Negative Syndrome ScaleDepressionGeneral symptomsMiddle Agedmedicine.disease030227 psychiatry3. Good healthHospitalizationAffectPsychiatry and Mental healthResearch DesignSchizophreniaAcute DiseaseGuiltSchizophreniaFemaleSchizophrenic PsychologyFactor Analysis StatisticalPsychologyPsychopathologyClinical psychologySchizophrenia spectrumEuropean Psychiatry
researchProduct

Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.

2005

Amisulpride is a clinically effective antipsychotic drug in a broad dose range with low propensity for extrapyramidal symptoms (EPS). Daily doses and plasma levels of amisulpride were analyzed within a large-scale therapeutic drug monitoring (TDM) survey to find plasma level ranges for optimized treatment under naturalistic conditions. Data of 378 schizophrenic patients treated with amisulpride (100-1550 mg) were included (40% female). Amisulpride plasma levels were analyzed at steady state; assessment comprised improvement (CGI-I) and side-effects, particularly EPS. For detection of cut-off values regarding non-response or EPS, receiver operating characteristics (ROC) curves were applied a…

AdultMalemedicine.medical_specialtyDyskinesia Drug-InducedAdolescentmedicine.drug_classStatistics as TopicAtypical antipsychoticPharmacologyGastroenterologyExtrapyramidal symptomsInternal medicineGermanymedicineHumansAmisulprideBiological PsychiatryAgedRetrospective StudiesAged 80 and overNeurologic ExaminationPsychiatric Status Rating ScalesReceiver operating characteristicmedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryDopamine antagonistMiddle Agedmedicine.diseasePsychiatry and Mental healthDose–response relationshipROC CurveSchizophreniaTherapeutic drug monitoringSchizophreniaFemalemedicine.symptomAmisulprideDrug MonitoringSulpiridebusinessmedicine.drugAntipsychotic AgentsJournal of psychiatric research
researchProduct

Functional signs in patients consulting for presumed Lyme borreliosis

2019

Little is known about the functional symptoms associated with Lyme borreliosis (LB) in Europe. We aimed to assess functional symptoms associated with presumed LB and to compare patients with and without confirmed LB.We performed a retrospective monocenter study. Patients consulting for presumed LB were included.Between November 2015 and June 2018, 355patients were included (mean age: 51years, 52% of women) of which 48had LB: erythema migrans (42%), early disseminated LB (50%; 35% of neuroborreliosis cases), and late disseminated LB (8%). The most frequently reported functional symptoms were neuropathic pain (23%), arthralgia (23%), and asthenia (17%). Other functional symptoms were rare (≤1…

AdultMalemedicine.medical_specialtyFunctional symptomsDiagnosis Differential03 medical and health sciencesLyme diseasemedicineHumansLyme NeuroborreliosisLyme diseaseIn patientSerologic TestsReferral and ConsultationAgedRetrospective StudiesLyme borreliosis0303 health sciences030306 microbiologyLyme borreliosisbusiness.industryMean ageMiddle Agedmedicine.diseaseDermatology3. Good healthAnti-Bacterial Agents[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyInfectious DiseasesTreatment OutcomeBorrelia burgdorferiNeuropathic painErythema migransErythema Chronicum MigransFemaleFranceSymptom AssessmentbusinessNeuroborreliosis[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Effects of Particulate Matter on the Incidence of Respiratory Diseases in the Pisan Longitudinal Study

2020

The current study aimed at assessing the effects of exposure to Particulate Matter (PM) on the incidence of respiratory diseases in a sub-sample of participants in the longitudinal analytical epidemiological study in Pisa, Italy. Three hundred and five subjects living at the same address from 1991 to 2011 were included. Individual risk factors recorded during the 1991 survey were considered, and new cases of respiratory diseases were ascertained until 2011. Average PM10 and PM2.5 exposures (&micro

AdultMalemedicine.medical_specialtyLongitudinal studyPercentilelong-term exposureair pollution;Health Toxicology and Mutagenesisair pollutionRespiratory Tract Diseaseslcsh:Medicinerandom forest;010501 environmental sciencesLogistic regression01 natural sciencesArticle03 medical and health sciences0302 clinical medicinequestionnaire;Environmental healthEpidemiologyMedicineHumansLongitudinal StudiesRespiratory systemRespiratory healthrespiratory symptoms/diseases0105 earth and related environmental sciencesAgedparticulate matterAir Pollutantsbusiness.industryIncidence (epidemiology)questionnaireIncidencelcsh:RPublic Health Environmental and Occupational HealthEnvironmental ExposureParticulatesMiddle Aged030228 respiratory systemItalyFemalebusinessrandom forestparticulate matter;International Journal of Environmental Research and Public Health
researchProduct